发明名称 Monodisperse hexameric acylated insulin analog formulations
摘要 The present invention provides formulations and methods for preparing formulations containing an aqueous solution at a pH of greater than about 7.9. The aqueous solution includes an isotonicity agent, a phenolic derivative, zinc ions, and an acylated human insulin analog. More particularly, the invention relates to formulations having a pH of greater than about 7.9 that include a monoacylated human insulin analog such as an acylated des(B30) human insulin analog or an analog that comprises a native or modified human insulin A chain optionally modified at position A21, and a modified native human insulin B chain optionally modified at position B3 and modified at position B28, or at both positions B28 and B29, and that contains a lysine residue at either position B28 or B29 acylated with a fatty acid residue. The invention also provides a method for treating a patient suffering from hyperglycemia using the pharmaceutical formulations of the invention.
申请公布号 AU2624400(A) 申请公布日期 2000.08.07
申请号 AU20000026244 申请日期 2000.01.26
申请人 ELI LILLY AND COMPANY 发明人 KINGMAN NG;SHUN LI;ERIC ALAN WATTS
分类号 A61K9/08;A61K9/00;A61K38/28;A61K47/02;A61K47/10;A61K47/12;A61K47/26;A61K47/42;A61P3/10 主分类号 A61K9/08
代理机构 代理人
主权项
地址